期刊文献+

急性缺血性卒中患者早期抗栓治疗影响因素的多水平模型分析 被引量:5

Multi-level analysis on factors affecting the adherence to early antithrombotic therapy among people with acute ischemic stroke
原文传递
导出
摘要 目的探索影响急性缺血性卒中(AIS)患者早期抗栓治疗实施的影响因素,为促进早期抗栓治疗提供参考。方法选取中国国家卒中登记Ⅱ(CNSRⅡ)研究中符合早期抗栓治疗条件的≥50岁AIS患者,收集患者及医院信息。对医院和患者因素与是否进行早期抗栓治疗进行单因素分析。以患者水平为水平1,医院水平为水平2,建立两水平logistic回归模型,分析医院和患者因素对是否进行早期抗栓治疗的影响。结果共纳入16910例患者,其中有14332例(84.75%)接受了早期抗栓治疗。单因素分析结果显示,早期抗栓治疗的患者相关因素包括年龄、医保类型、家庭人均月收入、血脂异常病史;医院相关因素包括医院级别、医院所在地区、是否为教学医院、是否有卒中单元、实行单病种质量控制、神经科床位数比例(P<0.05)。多水平模型显示,早期抗栓治疗的患者相关因素包括性别、年龄、家庭人均月收入、高血压病史、入院美国国立卫生研究院卒中量表(NIHSS)评分;医院相关因素包括神经科床位数比例和医院所在地区(P<0.05)。结论早期抗栓治疗实施与医院医疗水平相关,应对高龄和入院NIHSS评分高的AIS患者进行重点关注。 Objective To explore the patient and hospital related determinants of adherence to early antithrombotic therapy among patients with acute ischemic stroke (AIS). Methods AIS patients aged 50 years old or above who were eligible for early antithrombotic therapy, were included from the China National Stroke Registry Ⅱ(CNSR Ⅱ) project. Characteristics related to patients and hospitals were collected. Univariate analysis method was conducted to explore the correlation between hospital or patient-related determinants and early antithrombotic therapy. A 2-level logistic regression model was set up to identify patient and hospital-related variables that were associated with the adherence to early antithrombotic therapy, with patient as level 1 and hospital as level 2. Results A total of 16 910 patients were included in the study, with 14 332 (84.75%) of them having received early antithrombotic therapy. Results from the univariate analysis showed that the patient determinants to early antithrombotic therapy would include age, type of health insurance, average income and history of dyslipidemia. Hospital determinants would include factors as: level and region of the hospital, academic status, with/without stroke unit, quality control on single disease and the percentage of neurological beds in total beds (P<0.05). Data on multilevel model showed that the patient-related determinants on early antithrombotic therapy would include age, gender, average income, history of hypertension, National Institutes of Health Stroke Scale (NIHSS) score at admission while hospital related determinants would include percentage of neurological beds in total beds, and region of the hospital (P<0.05). Conclusions The quality of a hospital was associated with the adherence to early antithrombotic therapy. AIS patients at advanced age or with high NIHSS score at admission should be paid more attention.
作者 白旭 宋艳平 吕芯芮 饶夫阳 覃伟 黄馨莹 李子孝 刘宝花 姜勇 Bai Xu;Song Yanping;Lyu Xinrui;Rao Fuyang;Qin Wei;Huang Xinying;Li Zixiao;Liu Baohua;Jiang Yong(School of Public Health,Peking University,Beijing 100191,China;China National Clinical Research Center for Neurological Diseases,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China)
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2019年第6期610-615,共6页 Chinese Journal of Epidemiology
基金 国家重点研发计划精准医学研究专项(2016YFC0901000,2016YFC0901001) 国家重点研发计划重大慢性非传染性疾病防控研究专项(2018YFC1311703).
关键词 急性缺血性卒中 早期抗栓治疗 多水平模型 Acute ischemic stroke Antithrombotic therapy Multilevel model
  • 相关文献

参考文献5

二级参考文献30

  • 1曲东锋.血小板糖蛋白Ⅱb/Ⅲa抑制剂可增强药物和机械溶栓的疗效[J].国外医学(脑血管疾病分册),2005,13(1):38-38. 被引量:6
  • 2陶立群.我国老年慢性病现状及发展趋势[J].老龄问题研究,2006(3):17-29. 被引量:14
  • 3周志明.缺血性卒中二级预防中的抗血小板治疗[J].国外医学(脑血管疾病分册),2005,13(12):915-918. 被引量:7
  • 4Easton JD.Future perspectives for optimizing oral antiplatelet therapy(J).Cerebrovasc Dis,2001;11(1):23-8. 被引量:1
  • 5Iwamoto T,Kubo H,Takasaki M.Platelet activation in the cerebral circu-lation in different subtypes of ischemic stroke and Binswanger's disease(J).Stroke,1995;26(1):52-6. 被引量:1
  • 6Grau AJ,Ruf A,Vogt A,et al.Increased fraction of circulating aetivateel platelets in acute and previous cerebrovascular ischemia(J).Thromb Haemost,1998;80:298-301. 被引量:1
  • 7Antiplatelet Trialists'Collaboration.Collaborative overview of randomized trials of antiplatelet therapy,I:prevention of death,myocardial infarction,and stroke by prolonged antiplatelet therapy in various categories of pa-tients(J).BMJ,1994;308:81-106. 被引量:1
  • 8Johnson ES,Lanes SF,Wentworth CE,et al.A meta-regression analysis of the dose-response effect of aspirin on stroke(J).Arch Intern Med,1999;159:1248-53. 被引量:1
  • 9Diener HC,Cunha L,Forbes C,et al.European Stroke Prevention Stud-y.Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke(J).J Neurol Sci,1996;143(1-2):1-13. 被引量:1
  • 10Farrell B,Godwin J,Richards S,et al.The United Kingdom transient is-chaemic attack(UK-TIA)aspirin trial:final results(J).J Neurol Neuro-surg Psychiatry,1991;54(12):1044-54. 被引量:1

共引文献1174

同被引文献64

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部